Data from several modeling studies demonstrate that large-scale increases in human immunodeficiency virus (HIV) testing across settings with a high burden of HIV may produce the largest incidence reductions to support the US Ending the HIV Epidemic (EHE) initiative's goal of reducing new HIV infections 90% by 2030. Despite US Centers for Disease Control and Prevention's recommendations for routine HIV screening within clinical settings and at least yearly screening for individuals most at risk of acquiring HIV, fewer than half of US adults report ever receiving an HIV test. Furthermore, total domestic funding for HIV prevention has remained unchanged between 2013 and 2019. The authors describe the evidence supporting the value of expanded HIV testing, identify challenges in implementation, and present recommendations to address these barriers through approaches at local and federal levels to reach EHE targets.
Bibliographical noteFunding Information:
Financial support . This work was supported by the National Institutes on Drug Abuse [NIDA grant nos. R01DA041747] as declared by B. N., National Institutes of Health (NIH) (NIMH) [grant #K08MH118094], and NIH (NIMDH) [grant # R01MD018539] as declared by A. T. F., career development awards from the National Institute of Allergy and Infectious Diseases [K01AI38853] as declared by P. K., and Emory Center for AIDS Research NIH/NIAID [grant #P30AI050409) as declared by C. D. R.
© 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
- Ending the HIV Epidemic
- HIV prevention
- HIV testing
- simulation model
PubMed: MeSH publication types
- Journal Article